• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

母体接种肺炎球菌表面蛋白 A 可预防衍生后代的肺炎球菌感染。

Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.

机构信息

Department of Otolaryngology-Head and Neck Surgery, Wakayama Medical University, Wakayama-city, Wakayama, Japan.

出版信息

PLoS One. 2011;6(10):e27102. doi: 10.1371/journal.pone.0027102. Epub 2011 Oct 31.

DOI:10.1371/journal.pone.0027102
PMID:22073127
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3205068/
Abstract

Pathogen-specific antibody plays an important role in protection against pneumococcal carriage and infections. However, neonates and infants exhibit impaired innate and adaptive immune responses, which result in their high susceptibility to pneumococci. To protect neonates and infants against pneumococcal infection it is important to elicit specific protective immune responses at very young ages. In this study, we investigated the protective immunity against pneumococcal carriage, pneumonia, and sepsis induced by maternal immunization with pneumococcal surface protein A (PspA). Mother mice were intranasally immunized with recombinant PspA (rPspA) and cholera toxin B subunit (CTB) prior to being mated. Anti-PspA specific IgG, predominantly IgG1, was present at a high level in the serum and milk of immunized mothers and in the sera of their pups. The pneumococcal densities in washed nasal tissues and in lung homogenate were significantly reduced in pups delivered from and/or breast-fed by PspA-immunized mothers. Survival after fatal systemic infections with various types of pneumococci was significantly extended in the pups, which had received anti-PspA antibody via the placenta or through their milk. The current findings strongly suggest that maternal immunization with PspA is an attractive strategy against pneumococcal infections during early childhood.

摘要

病原体特异性抗体在预防肺炎球菌定植和感染方面发挥着重要作用。然而,新生儿和婴儿的固有和适应性免疫反应受损,导致他们对肺炎球菌高度易感。为了保护新生儿和婴儿免受肺炎球菌感染,在非常年幼的时候引发特定的保护性免疫反应非常重要。在这项研究中,我们研究了通过肺炎球菌表面蛋白 A(PspA)的母体免疫接种引起的对肺炎球菌定植、肺炎和败血症的保护免疫。在交配前,母鼠通过鼻腔内免疫接种重组 PspA(rPspA)和霍乱毒素 B 亚单位(CTB)。免疫母鼠的血清和乳汁中存在高水平的抗 PspA 特异性 IgG,主要是 IgG1,而其幼崽的血清中也存在抗 PspA 特异性 IgG,主要是 IgG1。经 rPspA 免疫的母鼠所产幼崽的鼻腔组织和肺匀浆中的肺炎球菌密度明显降低。通过胎盘或通过乳汁获得抗 PspA 抗体的幼崽在致命性全身感染各种类型的肺炎球菌后,存活时间明显延长。这些发现强烈表明,用 PspA 进行母体免疫接种是预防儿童早期肺炎球菌感染的一种有吸引力的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/ef20ec3e9065/pone.0027102.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/46c7d71c7f11/pone.0027102.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/1e301a331429/pone.0027102.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/a072cf88616e/pone.0027102.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/107d6bc3a116/pone.0027102.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/5ba76ad912c8/pone.0027102.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/a75c424b8065/pone.0027102.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/ffdcc3b0ff48/pone.0027102.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/ef20ec3e9065/pone.0027102.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/46c7d71c7f11/pone.0027102.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/1e301a331429/pone.0027102.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/a072cf88616e/pone.0027102.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/107d6bc3a116/pone.0027102.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/5ba76ad912c8/pone.0027102.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/a75c424b8065/pone.0027102.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/ffdcc3b0ff48/pone.0027102.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db91/3205068/ef20ec3e9065/pone.0027102.g008.jpg

相似文献

1
Maternal immunization with pneumococcal surface protein A protects against pneumococcal infections among derived offspring.母体接种肺炎球菌表面蛋白 A 可预防衍生后代的肺炎球菌感染。
PLoS One. 2011;6(10):e27102. doi: 10.1371/journal.pone.0027102. Epub 2011 Oct 31.
2
Protection against systemic fatal pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A (PspA).通过母体鼻内接种肺炎球菌表面蛋白A(PspA)预防全身性致死性肺炎球菌感染。
J Infect Chemother. 2008 Dec;14(6):393-8. doi: 10.1007/s10156-008-0647-7. Epub 2008 Dec 17.
3
Protection of pneumococcal infection by maternal intranasal immunization with pneumococcal surface protein A.通过母体鼻腔内接种肺炎球菌表面蛋白A预防肺炎球菌感染
Adv Otorhinolaryngol. 2011;72:121-5. doi: 10.1159/000324656. Epub 2011 Aug 18.
4
Intranasal immunization with recombinant PspA fused with a flagellin enhances cross-protective immunity against Streptococcus pneumoniae infection in mice.鼻腔内免疫重组 PspA 与鞭毛蛋白融合增强了对肺炎链球菌感染的小鼠交叉保护免疫。
Vaccine. 2011 Aug 5;29(34):5731-9. doi: 10.1016/j.vaccine.2011.05.095. Epub 2011 Jun 13.
5
Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infection.用肺炎链球菌表面蛋白A(PspA)进行口服免疫可引发针对肺炎链球菌感染的保护性体液免疫。
Infect Immun. 1997 Feb;65(2):640-4. doi: 10.1128/iai.65.2.640-644.1997.
6
Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.黏膜免疫接种靶向肺炎链球菌 PspA 至人 Fcγ 受体 I 型的无佐剂疫苗可通过补体和乳铁蛋白介导的杀菌活性来预防肺炎球菌感染。
Infect Immun. 2012 Mar;80(3):1166-80. doi: 10.1128/IAI.05511-11. Epub 2011 Dec 12.
7
Maternal immunization with pneumococcal surface protein A provides the immune memories of offspring against pneumococcal infection.母体接种肺炎球菌表面蛋白 A 为后代提供针对肺炎球菌感染的免疫记忆。
Front Cell Infect Microbiol. 2023 Mar 23;13:1059603. doi: 10.3389/fcimb.2023.1059603. eCollection 2023.
8
Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice.鼻内免疫肺炎球菌表面蛋白 A(PspA)佐剂细菌样颗粒对小鼠肺炎链球菌感染的保护作用。
Microb Pathog. 2018 Oct;123:115-119. doi: 10.1016/j.micpath.2018.06.041. Epub 2018 Jun 26.
9
Protection Elicited by Nasal Immunization with Recombinant Pneumococcal Surface Protein A (rPspA) Adjuvanted with Whole-Cell Pertussis Vaccine (wP) against Co-Colonization of Mice with Streptococcus pneumoniae.用全细胞百日咳疫苗(wP)佐剂重组肺炎球菌表面蛋白A(rPspA)经鼻免疫诱导的对小鼠肺炎链球菌共定植的保护作用。
PLoS One. 2017 Jan 19;12(1):e0170157. doi: 10.1371/journal.pone.0170157. eCollection 2017.
10
Genetic immunization with the region encoding the alpha-helical domain of PspA elicits protective immunity against Streptococcus pneumoniae.用编码肺炎链球菌表面蛋白A(PspA)α-螺旋结构域的区域进行基因免疫可引发针对肺炎链球菌的保护性免疫。
Infect Immun. 2001 Sep;69(9):5456-63. doi: 10.1128/IAI.69.9.5456-5463.2001.

引用本文的文献

1
Consequences of host-microbiome interactions in preterm infants.早产儿宿主-微生物组相互作用的后果。
Infect Immun. 2025 Sep 9;93(9):e0050124. doi: 10.1128/iai.00501-24. Epub 2025 Aug 11.
2
Development of a broad-spectrum epitope-based vaccine against Streptococcus pneumoniae.一种针对肺炎链球菌的基于广谱表位的疫苗的研发。
PLoS One. 2025 Jan 16;20(1):e0317216. doi: 10.1371/journal.pone.0317216. eCollection 2025.
3
Robust Immune Response and Protection against Lethal Pneumococcal Challenge with a Recombinant BCG-PspA-PdT Prime/Boost Scheme Administered to Neonatal Mice.

本文引用的文献

1
Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.肺炎球菌疾病预防的进展:婴幼儿 13 价肺炎球菌结合疫苗。
Clin Infect Dis. 2011 May;52(10):1241-7. doi: 10.1093/cid/cir142.
2
Efficient mucosal vaccination mediated by the neonatal Fc receptor.新生儿 Fc 受体介导的高效黏膜疫苗接种。
Nat Biotechnol. 2011 Feb;29(2):158-63. doi: 10.1038/nbt.1742. Epub 2011 Jan 16.
3
Public health and economic impact of the 13-valent pneumococcal conjugate vaccine (PCV13) in the United States.
用重组卡介苗-肺炎球菌表面蛋白A-破伤风类毒素初免/加强免疫方案对新生小鼠进行免疫可引发强大免疫反应并保护其免受致死性肺炎球菌攻击
Vaccines (Basel). 2024 Jan 25;12(2):122. doi: 10.3390/vaccines12020122.
4
Maternal immunization with pneumococcal surface protein A provides the immune memories of offspring against pneumococcal infection.母体接种肺炎球菌表面蛋白 A 为后代提供针对肺炎球菌感染的免疫记忆。
Front Cell Infect Microbiol. 2023 Mar 23;13:1059603. doi: 10.3389/fcimb.2023.1059603. eCollection 2023.
5
Immunoinformatics-aided design of a new multi-epitope vaccine adjuvanted with domain 4 of pneumolysin against Streptococcus pneumoniae strains.免疫信息学辅助设计一种新型多表位疫苗,该疫苗佐以肺炎溶血素第4结构域,用于针对肺炎链球菌菌株。
BMC Bioinformatics. 2023 Feb 24;24(1):67. doi: 10.1186/s12859-023-05175-6.
6
Protective responses of an engineered PspA recombinant antigen against .一种工程化PspA重组抗原的保护性反应针对…… (原文不完整,翻译至此)
Biotechnol Rep (Amst). 2019 Oct 30;24:e00385. doi: 10.1016/j.btre.2019.e00385. eCollection 2019 Dec.
7
Cationic pullulan nanogel as a safe and effective nasal vaccine delivery system for respiratory infectious diseases.阳离子普鲁兰纳米凝胶作为一种安全有效的呼吸道传染病鼻用疫苗传递系统。
Hum Vaccin Immunother. 2018;14(9):2189-2193. doi: 10.1080/21645515.2018.1461298. Epub 2018 Jul 19.
8
Transmission Is Blocked by Type-Specific Immunity in an Infant Mouse Model.在幼鼠模型中,传播被型特异性免疫阻断。
mBio. 2017 Mar 14;8(2):e00188-17. doi: 10.1128/mBio.00188-17.
9
Cholera toxin B: one subunit with many pharmaceutical applications.霍乱毒素B:具有多种药物应用的一个亚基。
Toxins (Basel). 2015 Mar 20;7(3):974-96. doi: 10.3390/toxins7030974.
10
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.基于纳米凝胶的肺炎球菌表面蛋白A鼻用疫苗在猕猴中诱导与微小RNA相关的Th17细胞反应,并产生针对肺炎链球菌的中和抗体。
Mucosal Immunol. 2015 Sep;8(5):1144-53. doi: 10.1038/mi.2015.5. Epub 2015 Feb 11.
在美国,13 价肺炎球菌结合疫苗(PCV13)的公共卫生和经济影响。
Vaccine. 2010 Nov 10;28(48):7634-43. doi: 10.1016/j.vaccine.2010.09.049. Epub 2010 Sep 28.
4
Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae.分泌型免疫球蛋白 A 抗体在抵抗肺炎链球菌感染中发挥重要作用。
J Immunol. 2010 Aug 1;185(3):1755-62. doi: 10.4049/jimmunol.1000831. Epub 2010 Jun 28.
5
Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A).通过用编码 PspA(肺炎球菌表面蛋白 A)的 DNA 疫苗进行的皮内免疫预防肺炎链球菌的鼻腔定植。
Microb Pathog. 2010 Jun;48(6):205-13. doi: 10.1016/j.micpath.2010.02.009. Epub 2010 Mar 4.
6
Immunization of mice with single PspA fragments induces antibodies capable of mediating complement deposition on different pneumococcal strains and cross-protection.用单个肺炎球菌表面蛋白A(PspA)片段免疫小鼠可诱导产生能够介导补体在不同肺炎球菌菌株上沉积并产生交叉保护作用的抗体。
Clin Vaccine Immunol. 2010 Mar;17(3):439-46. doi: 10.1128/CVI.00430-09. Epub 2010 Jan 20.
7
Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates.5岁以下儿童肺炎链球菌所致疾病负担:全球估计数
Lancet. 2009 Sep 12;374(9693):893-902. doi: 10.1016/S0140-6736(09)61204-6.
8
Serotype replacement in perspective.血清型替代的前景。
Vaccine. 2009 Aug 21;27 Suppl 3:C22-4. doi: 10.1016/j.vaccine.2009.06.004. Epub 2009 Jun 21.
9
Human milk-derived B cells: a highly activated switched memory cell population primed to secrete antibodies.人乳来源的B细胞:一个高度活化的已转换记忆细胞群体,准备好分泌抗体。
J Immunol. 2009 Jun 1;182(11):7155-62. doi: 10.4049/jimmunol.0803107.
10
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice.用肺炎链球菌表面蛋白A(PspA)与Toll样受体激动剂的混合物进行鼻内免疫可诱导特异性抗体,并增强小鼠气道内细菌的清除。
Vaccine. 2009 May 21;27(24):3181-8. doi: 10.1016/j.vaccine.2009.03.055. Epub 2009 Apr 8.